Fig 1.
Flow chart of NHANES cycles 2003–2004 to 2015–2016 full sample to final analytic sample.
Table 1.
Characteristics of 5101 U.S. adults aged 18–64 years old, NHANES 2003–2004 to 2015–2016.
Fig 2.
Sex-specific prevalence of cancer risk groups and frequency of HPV subtypes according to cancer risk groups.
Panel B) Individuals with multiple infections of a specific cancer group appear as multiple counts if they have multiple HPV infections. For example, if an individual has an HPV type 6 and 11 infection, they will appear as a count for both bars 6 and 11. HPV testing was done through vaginal swabs for females (18-59y, 2003–2004 to 2015–2016) and penile swabs for males (18-59y, 2013–2014 to 2015–16) using Roche Linear Array Assays, and oral swabs for both males and females (18-69y, 2009–2010 to 2015–2016).
Fig 3.
Kaplan-Meier curves across cancer risk groups, stratified by sex.
Survival differences across cancer risk groups was assessed by global chi-squared analysis.
Table 2.
Odds of MetS across cancer risk groups, stratified by sex.
Table 3.
Effects of HPV on risk of mortality, stratified by sex.
Fig 4.
Effects of HPV and MetS on risk of mortality, stratified by sex.
These figures provide results of cox regressions to assess risk of mortality across cross-classified cancer risk groups and MetS in unadjusted and fully adjusted models, across males and females. HR = hazard ratio.